 | Up a level |
von Deimling, Markus; Mertens, Laura S; Furrer, Marc; Li, Roger; Tendijck, Guus A H; Taylor, Jacob; Crocetto, Felice; Maas, Moritz; Mari, Andrea; Pichler, Renate; Moschini, Marco; Tully, Karl H; D'Andrea, David; Laukhtina, Ekaterina; Del Giudice, Francesco; Marcq, Gautier; Velev, Maud; Gallioli, Andrea; Albisinni, Simone; Mori, Keiichiro; ... (2024). The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer. (In Press). BJU international Wiley 10.1111/bju.16319
von Deimling, Markus; Furrer, Marc; Mertens, Laura S; Mari, Andrea; van Ginkel, Noor; Bacchiani, Mara; Maas, Moritz; Pichler, Renate; Li, Roger; Moschini, Marco; Bianchi, Alberto; Vetterlein, Malte W; Lonati, Chiara; Crocetto, Felice; Taylor, Jacob; Tully, Karl H; Afferi, Luca; Soria, Francesco; Del Giudice, Francesco; Longoni, Mattia; ... (2024). Impact of the Extent of Lymph Node Dissection on Survival Outcomes in Clinically Lymph Node-Positive Bladder Cancer. BJU international, 133(3), pp. 341-350. Wiley 10.1111/bju.16210
Marcq, Gautier; Afferi, Luca; Neuzillet, Yann; Nykopp, Timo; Voskuilen, Charlotte S; Furrer, Marc A; Kassouf, Wassim; Aziz, Atiqullah; Bajeot, Anne Sophie; Alvarez-Maestro, Mario; Black, Peter; Roupret, Morgan; Noon, Aidan P; Seiler, Roland; Hendricksen, Kees; Roumiguie, Mathieu; Pang, Karl H; Laine-Caroff, Paul; Xylinas, Evanguelos; Ploussard, Guillaume; ... (2022). Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group. Cancers, 14(23) MDPI AG 10.3390/cancers14235740
Tully, Karl H; Moschini, Marco; von Rundstedt, Friedrich-Carl E; Aziz, Atiqullah; Kluth, Luis A; Necchi, Andrea; Rink, Michael; Hendricksen, Kees; Sargos, Paul; Vetterlein, Malte W; Seiler, Roland; Poyet, Cedric; Krajewski, Wojciech; Fajkovic, Harun; Shariat, Shahrokh F; Xylinas, Evanguelos; Roghmann, Florian (2020). Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size. Urologic oncology, 38(11), 851.e19-851.e25. Elsevier 10.1016/j.urolonc.2020.06.034
Witjes, J Alfred; Babjuk, Marek; Bellmunt, Joaquim; Bruins, H Maxim; De Reijke, Theo M; De Santis, Maria; Gillessen, Silke; James, Nicholas; Maclennan, Steven; Palou, Juan; Powles, Tom; Ribal, Maria J; Shariat, Shahrokh F; Van Der Kwast, Theo; Xylinas, Evanguelos; Agarwal, Neeraj; Arends, Tom; Bamias, Aristotle; Birtle, Alison; Black, Peter C; ... (2020). Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250]. European urology, 78(1), e48-e50. Elsevier 10.1016/j.eururo.2020.03.017
Witjes, J Alfred; Babjuk, Marek; Bellmunt, Joaquim; Bruins, H Maxim; De Reijke, Theo M; De Santis, Maria; Gillessen, Silke; James, Nicholas; Maclennan, Steven; Palou, Juan; Powles, Tom; Ribal, Maria J; Shariat, Shahrokh F; Der Kwast, Theo Van; Xylinas, Evanguelos; Agarwal, Neeraj; Arends, Tom; Bamias, Aristotle; Birtle, Alison; Black, Peter C; ... (2020). EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees. European urology, 77(2), pp. 223-250. Elsevier 10.1016/j.eururo.2019.09.035
Moschini, Marco; Spahn, Martin; Mattei, Agostino; Cheville, John; Karnes, R Jeffrey (2016). Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics. BMC medicine, 14(1), p. 67. BioMed Central 10.1186/s12916-016-0613-7
Spahn, Martin; Boxler, Silvan; Joniau, Steven; Moschini, Marco; Tombal, Bertrand; Karnes, R Jeffrey (2015). What is the Need for Prostatic Biomarkers in Prostate Cancer Management? Current urology reports, 16(10), p. 70. Current Science 10.1007/s11934-015-0545-3
